Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stand-alone Blood Pump Business Model is expected to Enable Expanded Use and Increased Adoption of CytoSorb PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- CytoSorbents Corporation
Jacob School of Medicine announced a clinical research trial with Pfizer for children ages 12 to 17.
Stand-alone Blood Pump Business Model is expected to Enable Expanded Use and Increased Adoption of CytoSorb®PRINCETON, N.J., June 1, 2022 /PRNewsw...
/PRNewswire/ -- A unique collaborative enterprise of academic and pharmaceutical experts in New York City and Northern New Jersey have formed a regional drug...
/PRNewswire/ -- A unique collaborative enterprise of academic and pharmaceutical experts in New York City and Northern New Jersey have formed a regional drug...